Literature DB >> 9496182

Height and weight in cystic fibrosis: a cross sectional study. UK Cystic Fibrosis Survey Management Committee.

S Morison1, J A Dodge, T J Cole, P A Lewis, E C Coles, D Geddes, G Russell, J M Littlewood, M T Scott.   

Abstract

Cross sectional data reporting the height, weight, and body mass index of UK patients with cystic fibrosis are presented. During the first decade of life height and weight in patients with cystic fibrosis are maintained at about 0.5 SD below those of the general population, which reflects an improvement over earlier published observations. Postpubertal stature and weight maintenance in the cystic fibrosis population still show substantial deficits which may be related to treatment.

Entities:  

Mesh：

Year:  1997        PMID： 9496182      PMCID： PMC1717401          DOI： 10.1136/adc.77.6.497

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  10 in total

1.  Some statistical data on atypical cholinesterase of human serum.

Authors:  W KALOW; D R GUNN
Journal:  Ann Hum Genet       Date:  1959-07       Impact factor: 1.670

2.  Gender gap in cystic fibrosis mortality.

Authors:  M Rosenfeld; R Davis; S FitzSimmons; M Pepe; B Ramsey
Journal:  Am J Epidemiol       Date:  1997-05-01       Impact factor: 4.897

3.  Dietary supplement and nutrition in children with cystic fibrosis.

Authors:  H K Berry; F W Kellogg; M M Hunt; R L Ingberg; L Richter; C Gutjahr
Journal:  Am J Dis Child       Date:  1975-02

4.  Cross sectional stature and weight reference curves for the UK, 1990.

Authors:  J V Freeman; T J Cole; S Chinn; P R Jones; E M White; M A Preece
Journal:  Arch Dis Child       Date:  1995-07       Impact factor: 3.791

5.  Relative underweight in cystic fibrosis and its prognostic value.

Authors:  R Kraemer; A Rüdeberg; B Hadorn; E Rossi
Journal:  Acta Paediatr Scand       Date:  1978-01

6.  Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee.

Authors:  J A Dodge; S Morison; P A Lewis; E C Coles; D Geddes; G Russell; J M Littlewood; M T Scott
Journal:  Arch Dis Child       Date:  1997-12       Impact factor: 3.791

7.  A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto.

Authors:  M Corey; F J McLaughlin; M Williams; H Levison
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

8.  Smoothing reference centile curves: the LMS method and penalized likelihood.

Authors:  T J Cole; P J Green
Journal:  Stat Med       Date:  1992-07       Impact factor: 2.373

9.  Body mass index reference curves for the UK, 1990.

Authors:  T J Cole; J V Freeman; M A Preece
Journal:  Arch Dis Child       Date:  1995-07       Impact factor: 3.791

10.  Cystic fibrosis in the United Kingdom, 1968-1988: incidence, population and survival.

Authors:  J A Dodge; S Morison; P A Lewis; E C Colest; D Geddes; G Russell; A D Jackson; B Bentley
Journal:  Paediatr Perinat Epidemiol       Date:  1993-04       Impact factor: 3.980
  10 in total
  26 in total

Review 1.  Women with cystic fibrosis and their potential for reproduction.

Authors:  F P Edenborough
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

Review 2.  Growth and growth charts in cystic fibrosis.

Authors:  Leena Patel; Moira Dixon; T J David
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

3.  The use of local reference growth charts for clinical use or a universal standard: a balanced appraisal.

Authors:  S Milani; J M H Buckler; C J H Kelnar; L Benso; G Gilli; I Nicoletti; G Faglia; G Radetti; G Bona; Y Schonbeck; S Van Buuren; M Hermanussen; G Grugni; N Marazzi; P B Júlíusson; M Roelants; K Hoppenbrouwers; R Hauspie; R Bjerknes; H Lejarraga; A Sartorio
Journal:  J Endocrinol Invest       Date:  2012-02       Impact factor: 4.256

4.  Age related reference ranges of respiratory rate and heart rate for children in South Africa.

Authors:  L A Wallis; I Maconochie
Journal:  Arch Dis Child       Date:  2006-01-06       Impact factor: 3.791

5.  Inferences for health provision from survival data in cystic fibrosis.

Authors:  P A Lewis
Journal:  Arch Dis Child       Date:  1998-10       Impact factor: 3.791

6.  Pigs and humans with cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth.

Authors:  Mark P Rogan; Leah R Reznikov; Alejandro A Pezzulo; Nicholas D Gansemer; Melissa Samuel; Randall S Prather; Joseph Zabner; Douglas C Fredericks; Paul B McCray; Michael J Welsh; David A Stoltz
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

7.  Adequacy of clinical formulae for estimation of energy requirements in children with cystic fibrosis.

Authors:  J J Reilly; T J Evans; J Wilkinson; J Y Paton
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

8.  Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project.

Authors:  G Steinkamp; B Wiedemann
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

9.  Increased SULT1E1 activity in HepG2 hepatocytes decreases growth hormone stimulation of STAT5b phosphorylation.

Authors:  Li Li; Dongning He; Teresa W Wilborn; Josie L Falany; Charles N Falany
Journal:  Steroids       Date:  2008-09-11       Impact factor: 2.668

10.  Common CFTR gene variants influence body composition and survival in rural Ghana.

Authors:  Maris Kuningas; David van Bodegom; Linda May; Johannes J Meij; P Eline Slagboom; Rudi G J Westendorp
Journal:  Hum Genet       Date:  2009-11-05       Impact factor: 4.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.